Save the Date
November 18 – 19, 2020 • Harvard Medical School, Boston, MA
The 16th Annual Personalized Medicine Conference is being organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.
EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition
Bonnie J. Addario
Co-Founder, Chair, GO2 Foundation for Lung Cancer
Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)
Director, Government Affairs, Genentech
Director, Alliance Development, Biotechnology Innovation Organization
William S. Dalton, Ph.D., M.D.
Founder, Executive Chairman, M2Gen
Stephen L. Eck, M.D., Ph.D.
Chief Medical Officer, Immatics US
Okan Ekinci, M.D., M.B.A.
Chief Medical Officer, Roche Diagnostics Information Solutions
Lori Frank, Ph.D.
Memory Screening Advisory Board Member, Alzheimer’s Foundation of America
Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator
Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare
President, American Association of Kidney Patients
President, National Pharmaceutical Council
Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Precision Medicine, Novartis
Founder, CEO, Genome Creative
Howard McLeod, Pharm.D.
Founder, Managing Partner, GreyBird Ventures LLC
Lincoln Nadauld, M.D., Ph.D.
Chief, Precision Health, Intermountain Healthcare
Michael J. Pellini, M.D.
Managing Partner, Section 32
Vice President, Global Head of Market Access, Illumina
Marshall Ruffin, M.D.
Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Worldwide Research & Development, Pfizer
Michael Sherman, M.D.
Chief Medical Officer, Senior Vice President, Harvard Pilgrim Health Care
Senior Vice President, External Affairs, Tempus
Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University
Chief Corporate Communications and Culture Officer, SomaLogic
Mark P. Stevenson
Executive Vice President, Chief Operating Officer, Thermo Fisher Scientific
Apostolia M. Tsimberidou, M.D., Ph.D.
Tenured Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting
Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson & Johnson
Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Quest Diagnostics